在急诊室急性胸痛患者的多标志物方法
Andrea Piccioni1, Silvia Baroni2, Federica Manca1
1Department of Emergency, Anesthesiological and Reanimation Sciences, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, 00168 Roma, Italy.
新的生物标志物可溶性尿素酶等离子激素激活体受体 (suPAR) 和瘤亡因子受体2 (sST2),以及高灵敏度的托洛I (hsTnI),有助于诊断急性冠状动脉综合征 (ACS) 和预测胸痛患者的心血管事件.
科学领域:
- 心脏病学 心脏病学
- 生物标志物发现发现
- 紧急医疗 紧急医疗
背景情况:
- 胸痛是急诊室常见的诊断挑战,需要区分心脏和非心脏原因.
- 急性冠状动脉综合征 (ACS) 是一个关键的诊断,仅用标准标准就可能很困难.
- 越来越多地使用多标志物方法来提高胸痛患者的诊断准确性和预后.
研究的目的:
- 评估新型生物标志物的有用性,可溶性尿素激酶血激活因子受体 (suPAR) 和瘤亡因子受体2 (sST2),与高灵敏性热素I (hsTnI) 一起使用.
- 为了评估这些生物标志物的预后价值,患者呈现胸痛.
- 确定这些标记能否改善风险分层,并指导紧急情况下的临床决策.
主要方法:
- 一项观察性,前性,单中心研究包括360名典型胸痛患者和120名健康对照.
- 生物化学标志物hsTnI,sST2和suPAR在急诊室患者身上进行测量.
- 进行了12个月的随访,以监测不良事件.
主要成果:
- 被诊断为ACS的患者表现出高hsTnI,sST2 (> 24.19 ng/mL) 和suPAR (> 2.9 ng/mL).
- 一个具有中间hsTnI,高sST2 (>29.1 ng/mL) 和高suPAR (>2.9 ng/mL) 的小组显示出不良事件的可能性最高.
- 低hsTnI,sST2 (<24.19 ng/mL) 和suPAR (<2.9 ng/mL) 的患者在12个月的随访期间没有任何不良事件.
结论:
- 除了hsTnI外,sST2和suPAR可以通过表明内皮损伤来改善心血管病患者的预后.
- 这些生物标志物有望预测胸痛患者的不良事件,并可能指导进一步的诊断工作.
- 将suPAR和sST2整合到标准协议中可以提高患者的管理,使得基于个体风险可以更安全地出院或及时入院.
更多相关视频
05:58Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
Published on: February 3, 2021
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
